Table 5

 Body weight

Patient groupTotal patients (n)Patients with beneficial effectBaseline (day –3 to 0) (mean (SD))Effect of treatment (treatment−baseline) (mean (SD))Effect at follow up (follow up−baseline) (mean (SD))
Patients: 16 short bowel syndrome (SBS) patients (11 with jejunostomy and five with colon in continuity) and five rechallenged patients (all with end jejunostomy).
Patients Nos 03 and 20 did not complete the follow up study period. Patient No 03 had only 30% colon and was excluded from group 5 (patients with ⩾50% colon).
R, patients rechallenged with the same dose divided in two injections—that is, 12R is the rechallenged patient No 12.
Effect of treatment: paired t test; treatment versus baseline, *p<0.05.
Effect at follow up: paired t test; follow up versus baseline, all non-significant (p>0.05).
Body weight (kg)1. SBS patients161158.4 (12.3)0.9 (2.1)0.4 (1.6)
2. SBS patients with end jejunostomy10760.7 (11.4)1.4 (2.6)0.6 (1.8)
3. SBS patients with ⩾50% colon5357.6 (13.5)0.0 (0.6)0.1 (0.8)
4. SBS patients, high dietary compliance10660.1 (13.0)0.1 (1.4)−0.2 (1.1)
5. Rechallenged (1st treatment)5460.8 (12.2)0.5 (1.7)−0.5 (1.4)
6. Rechallenged (2nd treatment)5560.1 (10.1)2.2 (1.1)*0.2 (1.2)